Vivani Medical, Inc.
VANI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $16 | $17 | $14 | $11 |
| G&A Expenses | $9 | $10 | $5 | $2 |
| SG&A Expenses | $9 | $10 | $5 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $2 | $0 |
| Operating Expenses | $25 | $27 | $21 | $13 |
| Operating Income | -$25 | -$27 | -$21 | -$13 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $1 | $7 | $1 |
| Pre-Tax Income | -$23 | -$26 | -$14 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23 | -$26 | -$14 | -$13 |
| % Margin | – | – | – | – |
| EPS | -0.43 | -0.5 | -0.17 | -0.33 |
| % Growth | 14% | -194.1% | 48.5% | – |
| EPS Diluted | -0.43 | -0.5 | -0.17 | -0.33 |
| Weighted Avg Shares Out | 55 | 51 | 38 | 36 |
| Weighted Avg Shares Out Dil | 55 | 51 | 38 | 36 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$24 | -$25 | -$19 | -$13 |
| % Margin | – | – | – | – |